Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2526-2530
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2526
Table 2 Clinicopathological characteristics of 60 patients affected by gastric DLBCL
Clinicopathological characteristics
Age (yr)
Median58
Range19-76
Sex
Male42
Female28
Performance status
ECOG 00 (65%) (39/60)
ECOG 11 (28.3%) (17/60)
ECOG 22 (3.3%) (17/60)
Primary gastric site
Body18.3% (11/60)
Antrum46.6% (28/60)
Fundus10% (6/60)
Antrum-body25% (15/60)
Metastatic sites
No23.3% (14/60)
Node55% (33/60)
Pulmonary18.3% (11/60)
Bone0% (0/60)
Liver1.6% (1/60)
Spleen0% (0/60)
Pleural effusion1.6% (1/60)
Bio-humoral parameters
Lactate dehydrogenase (high level)85.0% (51/60)
β2 microglobulin (high level)60% (36/60)
Lugano staging system
I28.3% (17/60)
II46.6% (28/60)
III16.6% (10/60)
IV8.3% (5/60)
B symptoms15% (9/60)